From: Retrospective investigation of combination therapy with clarithromycin and levofloxacin for pulmonary Mycobacterium avium complex disease
Group
Follow-up period (months)
Start of treatment
1
3
6
12
Control
0/57 (0 %)
28/57 (49 %)
41/52 (79 %)
39/48 (81 %)
32/42 (76 %)
LVFX
0/18 (0 %)
5/18 (28 %)
*3/8 (38 %)
4/6 (67 %)
2/3 (67 %)